BackBlackRock Health Sciences Trust Overview
BlackRock Health Sciences Trust

BlackRock Health Sciences Trust Discounted Cash Flow

Is BME undervalued? Intrinsic value estimate stands at $1.3.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$1.29

Current Fair Value

$1.29
↓ 97.1% Downside

Overvalued by 97.1% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading

BlackRock Health Sciences Trust (BME) FAQ

BlackRock Health Sciences Trust (BME) currently reports a DCF fair value of $1.3. Use the charts on this page to explore BlackRock Health Sciences Trust's DCF fair value history and peer comparisons.

BlackRock Health Sciences Trust's discounted cash flow (DCF) fair value estimate is $1.3, about 97.1% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.

Start with the current DCF fair value of $1.3, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BlackRock Health Sciences Trust, and consider following BME for alerts when major investors trade the stock.